Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Owlstone Medical has developed a proprietary non-invasive breath analysis platform—Breath Biopsy—for early detection of disease through volatile organic compound profiling. The company’s technology enables biomarker discovery and validation across oncology, respiratory/liver/gastrointestinal diseases. Clinical studies are underway in lung cancer screening and chronic liver disease diagnosis. The company also offers commercial research services/products to pharma/academic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Owlstone Medical.